SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 427.80
arrow_downward
-1.52%(-6.60) 1H
2 Okt, 5:29:58 PTG GMT+2 · SEK
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk SOBI...
Buka
SEK 430.20
Tinggi
SEK 436.20
Rendah
SEK 425.60
Permodalan Pasaran
153.00B
Purata volum
265.66K
Volum
232.82K
Nisbah H/P
114.26
tgi 52 mgu
SEK 487.00
rdh 52 mgu
SEK 293.60
EPS
SEK 3.74
Syer tertunggak
357.64J
Bilangan pekerja
2K
Buka
SEK 430.20
Tinggi
SEK 436.20
Rendah
SEK 425.60
Permodalan Pasaran
153.00B
Purata volum
265.66K
Volum
232.82K
Nisbah H/P
114.26
tgi 52 mgu
SEK 487.00
rdh 52 mgu
SEK 293.60
EPS
SEK 3.74
Syer tertunggak
357.64J
Bilangan pekerja
2K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Invezz
·
13 jam lalu
Dow naik 260 mata selepas data pekerjaan lemah mengangkat saham AS
Business Insider
·
1 minit lalu
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
Simply Wall Street
·
3 minit lalu
Nasdaq (NDAQ) Stock May Be 3% Overvalued Following Calypso AI Launch
MarketForces Africa
·
15 minit lalu
XRP Trades At $1.48 Ahead Of Evernorth Nasdaq Debut, TP Shifts
Profil
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Perihal Swedish Orphan Biovitrum AB (publ)